TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Dedicare Life Science AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
34,460
|
53,327
|
53,468 |
Financial expenses |
18
|
7
|
3 |
Earnings before taxes |
2,332
|
10,747
|
10,397 |
EBITDA |
2,186
|
10,762
|
10,418 |
Total assets |
12,441
|
16,816
|
17,665 |
Current assets |
12,441
|
16,816
|
17,631 |
Current liabilities |
3,394
|
8,216
|
9,373 |
Equity capital |
9,047
|
8,600
|
8,292 |
- share capital |
101
|
95
|
98 |
Employees (average) |
16
|
23
|
17 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.7%
|
51.1%
|
46.9% |
Turnover per employee |
2,154
|
2,319
|
3,145 |
Profit as a percentage of turnover |
6.8%
|
20.2%
|
19.4% |
Return on assets (ROA) |
18.9%
|
64.0%
|
58.9% |
Current ratio |
366.6%
|
204.7%
|
188.1% |
Return on equity (ROE) |
25.8%
|
125.0%
|
125.4% |
Change turnover |
-22,650
|
1,466
|
22,425 |
Change turnover % |
-40%
|
3%
|
72% |
Chg. No. of employees |
-7
|
6
|
3 |
Chg. No. of employees % |
-30%
|
35%
|
21% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.